PF-Atlas › Mechanisms › Autotaxin/LPA1

Autotaxin/LPA1 in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

Autotaxin/LPA1 is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 1 clinical trial acting through this mechanism.

Drugs targeting Autotaxin/LPA1

Ziritaxestat

Clinical trials

Ziritaxestat — ISABELA-1/2
Medical disclaimer. This is a research summary, not medical advice.